Cilfa Opposition, Salmeterol, (Ar100687 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, cetirizine, (P990104039)
Countries: Argentina Date: 2002
-
CILFA opposition, neurokinin antagonist/H1 antagonist/H2 antagonists, (P990105080)
Countries: Argentina Date: 2002
-
CILFA opposition, SALMETEROL, (AR098867A1)
Countries: Argentina Date: 2016
-
CILFA opposition, Navafenterol sacchrinate in combination with corticosteroids, (AR097078A1)
Countries: Argentina Date: 2016
-
CILFA opposition, FXR and PPAR AGONIST, (AR103624A1)
Countries: Argentina Date: 2017
-
CILFA opposition, BACE Inhibitor (LY2886721), (AR103406A1)
Countries: Argentina Date: 2017
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, Levodopa - Carbidopa, (AR103448A1)
Countries: Argentina Date: 2017
-
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)
Countries: Argentina Date: 2017
-
CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)
Countries: Argentina Date: 2017